BRACCI, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 10.473
EU - Europa 9.134
AS - Asia 1.517
AF - Africa 30
OC - Oceania 20
SA - Sud America 20
Continente sconosciuto - Info sul continente non disponibili 11
Totale 21.205
Nazione #
US - Stati Uniti d'America 10.431
GB - Regno Unito 2.690
IE - Irlanda 1.506
CN - Cina 1.093
IT - Italia 1.091
SE - Svezia 934
UA - Ucraina 876
DE - Germania 614
RU - Federazione Russa 457
FR - Francia 440
FI - Finlandia 224
SG - Singapore 141
ES - Italia 123
VN - Vietnam 97
BE - Belgio 55
CA - Canada 38
TR - Turchia 34
PL - Polonia 30
CZ - Repubblica Ceca 26
IN - India 26
IR - Iran 26
CI - Costa d'Avorio 24
JP - Giappone 20
NL - Olanda 19
AU - Australia 17
HK - Hong Kong 16
EU - Europa 11
PH - Filippine 11
RO - Romania 11
PK - Pakistan 10
IL - Israele 8
AT - Austria 7
BR - Brasile 6
DK - Danimarca 6
PE - Perù 6
RS - Serbia 5
CL - Cile 4
EG - Egitto 4
LB - Libano 4
MX - Messico 4
AZ - Azerbaigian 3
BD - Bangladesh 3
HU - Ungheria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
BG - Bulgaria 2
CH - Svizzera 2
EC - Ecuador 2
EE - Estonia 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
MA - Marocco 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
ID - Indonesia 1
IS - Islanda 1
KR - Corea 1
LU - Lussemburgo 1
MT - Malta 1
MY - Malesia 1
PT - Portogallo 1
TH - Thailandia 1
VE - Venezuela 1
Totale 21.205
Città #
Southend 2.495
Dublin 1.490
Fairfield 1.461
Chandler 886
Menlo Park 844
Ashburn 817
Woodbridge 721
Jacksonville 712
Houston 568
Seattle 550
Wilmington 530
Ann Arbor 493
Siena 470
Cambridge 449
Princeton 273
Beijing 233
Nanjing 218
Boardman 128
Málaga 114
New York 113
San Mateo 109
Singapore 98
Shanghai 96
Dong Ket 91
Helsinki 91
Nanchang 91
San Diego 82
Fremont 62
Hebei 59
Shenyang 56
Dearborn 53
Brussels 51
Moscow 50
Florence 49
Washington 45
Rome 42
Redwood City 41
Tianjin 40
Kunming 38
Jiaxing 37
Jinan 30
Izmir 29
London 29
Changsha 28
Toronto 27
University Park 25
Abidjan 24
Lancaster 24
Brno 23
Bagno a Ripoli 21
Zhengzhou 20
Chicago 19
Düsseldorf 19
Milan 19
Norwalk 17
Venezia 17
Dallas 16
Los Angeles 16
Phoenix 16
Hangzhou 15
Ningbo 15
Nürnberg 15
San Francisco 15
Tappahannock 15
Gdansk 14
Munich 13
Guangzhou 12
Kansas City 12
Lanzhou 11
Lappeenranta 10
Amsterdam 9
Changchun 9
Kilburn 8
Manila 8
Taizhou 8
Zanjan 8
Arezzo 7
Atlanta 7
Auburn Hills 7
Colle Di Val D'elsa 7
Frankfurt am Main 7
Hong Kong 7
Hounslow 7
Napoli 7
Vienna 7
Haikou 6
Hefei 6
Leawood 6
Lima 6
Melbourne 6
Campagnano Di Roma 5
Canberra 5
Edinburgh 5
Hanoi 5
Hanover 5
Indiana 5
Naples 5
Palermo 5
Perugia 5
Philadelphia 5
Totale 15.605
Nome #
Effect of ligand binding on human D-amino acid oxidase: implications for the development of new drugs for schizophrenia treatment. 278
Near-infrared quantum dots labelled with a tumor selective tetrabranched peptide for in vivo imaging 265
The GAG-specific branched peptide NT4 reduces angiogenesis and invasiveness of tumor cells 254
Investigations into the killing activity of an antimicrobial peptide active against extensively antibiotic-resistant K. pneumoniae and P. aeruginosa 251
Insights into the role of sulfated glycans in cancer cell adhesion and migration through use of branched peptide probe 247
Heterologous Prime-Boost Combinations Highlight the Crucial Role of Adjuvant in Priming the Immune System 233
Efficacy and toxicity of the antimicrobial peptide M33 produced with different counter-ions. 218
Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the "Euro-Lupus Project" 215
Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug 211
Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow-induced chemoresistance in acute leukemias 207
In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate 206
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial Spectrum to Gram-Positive Bacterial Pathogens 204
A monoclonal antibody to a synthetic fragment of rabies virus glycoprotein binds ligands of the nicotinic cholinergic receptor 201
Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer 201
Tumor imaging with tetrabranched neurotensin 199
Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors. 194
Oxidative stress-induced apoptosis in peripheral blood lymphocytes from patients with POLG-related disorders 194
Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity 193
Supramolecular aggregates as drug carriers on cell expressing receptors for branched Neurotensin 192
Heparan sulfate proteoglycans can promote opposite effects on adhesion and directional migration of different cancer cells 189
Toxin-related antibodies with antimicrobial and antiviral activity 187
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 182
11β-hydroxysteroid dehydrogenase expression in first trimester human trophoblasts 181
High performance liquid chromatography immunoaffinity purification of antibodies and antibody fragments 176
Antipeptide monoclonal antibodies inhibit the binding of rabiesvirus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 174
Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis 172
A model of the rabies virus glycoprotein active site 171
A new NT4 peptide-based drug delivery system for cancer treatment 171
Branched peptides for tumor diagnosis and therapy 170
Coupling to a cancer-selective heparan-sulfate-targeted branched peptide can by-pass breast cancer cell resistance to methotrexate 169
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo. 169
Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens 169
Site-specific pegylation of an antimicrobial peptide increases resistance to Pseudomonas aeruginosa elastase 166
Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist 165
Branched Neurotensin For Tumor Targeting 165
null 165
Antimicrobial activity of levofloxacin - M33 peptide conjugation or combination 162
Branched peptides as bioactive molecules for drug design 160
An antimicrobial molecule mitigates signs of sepsis in vivo and eradicates infections from lung tissue 160
A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo 159
A novel phage-library-selected peptide inhibits human TNF-α binding to its receptors 159
Synthetic peptides in the form of dendrimers become resistant to protease activity 157
Antimicrobial peptide-loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections 157
Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept 154
Endogenous morphine modulates acute thermonociception in mice 152
Antibacterial and anti-inflammatory activity of an antimicrobial peptide synthesized with D amino acids 150
Proprietà di legame di anticorpi monoclonali contro il virus della rabbia ottenuti per mezzo di immunizzazione con un peptide sintetico 147
Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. 147
Antigenicity and immunogenicity of the V3 domain of HIV-1 gp120 expressed on the surface of Streptococcus gordonii. AIDS Res Hum Retroviruses 146
Purification of acidic synthetic peptides by high performance liquid chromatography using ammonium acetate buffer 145
Branched peptides as targeting agents for tumor imaging and therapy 144
Antigenicity of HIV-derived T-helper determinants in the context of carrier recombinant proteins: effect on T-helper cell repertoire selection 144
Bioactive peptides from libraries 143
HPLC immunoaffinity purification of rabies virus glycoprotein using immobilized antipeptide antibodies 143
An antigenic determinant common to human chorionic somatomammotropin and human growth hormone revealed by limited proteolysis of immune complexes 142
Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting 142
Characterization of immunoreactive octapeptides of human-cytomegalovirus gp58 141
Nanoparticles exposing neurotensin tumor-specific drivers. 141
Antimicrobial peptide, branched forms thereof, and their use in the treatment of bacterial infections 141
Antipeptide monoclonal antibodies inhibit the binding of rabies virus glycoprotein and alpha-bungarotoxin to the nicotinic acetylcholine receptor 141
Antibacterial peptides and analogues thereof 140
Exploiting Free-Energy Minima to Design Novel EphA2 Protein-Protein Antagonists: From Simulation to Experiment and Return 140
Branched multimeric peptides for tumor diagnosis and therapy 139
Peptide-protein interactions studied by surface plasmon and nuclear magnetic resonances 139
Targeting different LRP receptors and sulfated proteoglycan by branched neurotensin provide high cancer selectivity 139
HIV-1 and human myelin proteins share an antigenic determinant 138
HIV-1 gp 120 binding to nicotinig receptors 137
NMR studies of lysozyme surface accessibility by using different paramagnetic relaxation probes 137
Antagonistic activity of HIV-1 T helper peptides flanked by an unrelated carrier protein 136
Mimicking the nicotinic receptor binding site by a single chain Fv selected by competitive panning from a synthetic phage library 136
Branched neurotensin for tumor targeting 134
Three-dimensional computation of atom depth in complex molecular structures 134
Selective occlusion of tumor blood vessels by targeted delivery of an antibody-photosensitizer conjugate. 131
Immunomodulatory and anti-inflammatory activity in vitro and in vivo of a novel antimicrobial candidate. 131
Design and in vitro evaluation of branched peptide conjugates:turning nonspecific cytotoxic drugs into tumor-selective agents. 130
Metal ion complexation and folding of linear peptides 130
Immunogenicity of a free synthetic peptide: carrier-conjugation enhances antibody affinity for the native protein 129
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 129
Biochemical filtering of a protein-protein docking simulation identifies the structure of a complex between a recombinant antibody fragment and alpha-bungarotoxin 128
Determination of antigen-specific immunoglobulin content in ascitic fluids and antisera 128
Molecular basis of branched peptides resistance to enzyme proteolysis 128
The 208-222 region of the peplomer glycoprotein putative binding site of the rabiesvirus with the nicotinic acetylcholine receptor 127
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis 127
NMR studies of protein surface accessibility 127
Surface Plasmon Resonance analysis of HIV-1 gp 120 binding to muscle nicotinic receptors 126
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin 126
COMPOSTI ANTI TNF-ALPHA E LORO USI 125
Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations 125
Neurotensin-derived branched peptides and uses thereof 124
Binding of HIV-1 gp120 to the nicotinic receptor 123
Branched neurotensin specifically binds a highly selective tumor cell marker, which is not neurotensin receptor 1 123
Synthetic peptides of rubella E1 glycoprotein for serological assays 122
Mimotopes of the nicotinic receptor binding site selected by a combinatorial peptide library 122
Molecular definition of the interaction between a tumor-specific tetrabranched peptide and LRP6 receptor 122
BRANCHED PEPTIDES AS THERAPEUTICS 121
The development of antimicrobial peptides as new antibacterial drugs. 121
Structure-Activity Relationships and Mechanism of Action of Eph-ephrin Antagonists: Interaction of Cholanic Acid with the EphA2 Receptor. 120
Branched Neurotensin peptides for tumor personalized therapy 120
Synthetic antidotes against snake neurotoxins 119
Probing the surface of a sweet protein: NMR study of MNEI with a paramagnetic probe 119
Totale 15.833
Categoria #
all - tutte 64.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.519 0 0 313 652 309 330 349 495 341 373 110 247
2020/20213.410 149 331 56 287 138 498 279 460 333 367 237 275
2021/20222.250 156 265 150 228 131 82 113 111 97 247 203 467
2022/20233.194 186 326 410 446 340 609 61 257 246 144 125 44
2023/20242.382 79 76 237 119 102 684 826 50 9 43 17 140
2024/2025762 96 227 439 0 0 0 0 0 0 0 0 0
Totale 21.491